As per the terms of the LOI, Metabolix will conduct a series of validation production runs to demonstrate fermentation and recovery of Mirel biopolymer resin on full production-scale
The new cryogenic technology leverages sterile cryogenic ice fog to control the formation of ice crystals during the lyophilisation or freeze drying process and enhance lyophilisation cycles and
Novartis plans to ship more than 30 million doses of the Fluvirin vaccine which has been reformulated to include two new influenza strains. The reformulation meets the updated
The approved drug is used to treat rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), psoriatic arthritis (PsA), ankylosing spondylitis (AS), asthma and chronic obstructive pulmonary disease (COPD) . Horizon
The alliance is expected to build on the existing development and marketing agreement made between the two companies in 2010. As part of the alliance, GE Healthcare’s bioengineers
The withdrawal for the product, Purimune was issued after the company noticed an ingredient called galactooligosacharides, which tested positive for salmonella, according to the Chicago Tribune. The company
Initially, the new facility will manufacture Avicel colloidal MCC which is used as key ingredient in pharmaceutical and food and beverages industries. The company said the facility’s design
The trial will initially test the vaccine in up to 20 patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. ICT-121 is
Jentadueto is a new, single-tablet treatment option, taken twice daily, for adults with type 2 diabetes who need to improve control of their blood glucose. The European Commission
KPT-330, a selective inhibitor of nuclear export (SINE) chromosome region maintenance protein 1(CRM1) antagonist, is a mediator of nuclear export of p53, p73, pRb, FOXO, p21, p27, BRACA1,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.